Pharmacological antagonism of histamine H2R ameliorated L-DOPA–induced dyskinesia via normalization of GRK3 and by suppressing FosB and ERK in PD-Reference-Cited by-同舟云学术

Pharmacological antagonism of histamine H2R ameliorated L-DOPA–induced dyskinesia via normalization of GRK3 and by suppressing FosB and ERK in PD

Published:2019-09 Issue: Volume:81 Page:177-189
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Ahmed Mohamed Rafiuddin,Jayakumar Mithya,Ahmed Mohamed Sohail,Zamaleeva Alsu I.,Tao Juan,Li Eric Howard,Job Judith K.,Pittenger Christopher,Ohtsu Hiroshi,Rajadas Jayakumar^ORCID

Funder

GuoBin International LLC

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference53 articles.

1. Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment;Ahmed;J. Neurochem.,2008

2. Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation;Ahmed;J. Pharmacol. Exp. Ther.,2008

3. Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease;Ahmed;Sci. Transl Med.,2010

4. Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination;Ahmed;Biochemistry,2011

5. Overexpression of GRK6 rescues L-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats;Ahmed;Exp. Neurol.,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intranasal delivery of liposome encapsulated flavonoids ameliorates l-DOPA induced dyskinesia in hemiparkinsonian mice;Biomaterials;2024-12

2. Entanglement of MAPK pathways with gene expression and its omnipresence in the etiology for cancer and neurodegenerative disorders;Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms;2023-12

3. Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson’s Disease;Advances in Neurobiology;2023

4. Receptor and Ionic Mechanism of Histamine on Mouse Dorsolateral Striatal Neurons;Molecular Neurobiology;2022-10-17

5. Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics;Neurochemistry International;2022-06